Our Investors
Sofinnova Partners is France’s leading venture capital company, specializing in early stage companies in information technologies and life sciences in France and other European countries.
A sister company, Sofinnova Ventures, is based in San Francisco. In Life Sciences, Sofinnova Partners focuses on ambitious seed and start-up projects developing new therapeutics in both biopharmaceuticals and medical devices. Priority is given to companies that develop new products for unmet clinical needs within a sizeable market sector. Current investments managed are valued at €900 million.
